NCT03663283View on ClinicalTrials.gov

Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty

PHASE4CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

February 14, 2020

Study Completion Date

February 14, 2020

Conditions

Arthropathy Shoulder

Interventions

DRUG

Liposomal Bupivacaine

Interscalene Nerve Blocks

DRUG

Bupivacaine Hydrochloride

Interscalene Nerve Blocks

Trial Locations (1)

85054

Mayo Clinic in Arizona, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER